全文获取类型
收费全文 | 81879篇 |
免费 | 41743篇 |
国内免费 | 21篇 |
专业分类
耳鼻咽喉 | 1545篇 |
儿科学 | 4454篇 |
妇产科学 | 631篇 |
基础医学 | 16522篇 |
口腔科学 | 5132篇 |
临床医学 | 12970篇 |
内科学 | 23780篇 |
皮肤病学 | 7564篇 |
神经病学 | 13969篇 |
特种医学 | 2263篇 |
外科学 | 14165篇 |
综合类 | 53篇 |
一般理论 | 32篇 |
预防医学 | 4940篇 |
眼科学 | 1339篇 |
药学 | 5930篇 |
中国医学 | 1025篇 |
肿瘤学 | 7329篇 |
出版年
2024年 | 19篇 |
2023年 | 132篇 |
2022年 | 234篇 |
2021年 | 1607篇 |
2020年 | 5218篇 |
2019年 | 11102篇 |
2018年 | 10363篇 |
2017年 | 11645篇 |
2016年 | 12301篇 |
2015年 | 12148篇 |
2014年 | 12105篇 |
2013年 | 12600篇 |
2012年 | 4589篇 |
2011年 | 4530篇 |
2010年 | 9115篇 |
2009年 | 5471篇 |
2008年 | 2335篇 |
2007年 | 1143篇 |
2006年 | 1179篇 |
2005年 | 888篇 |
2004年 | 892篇 |
2003年 | 855篇 |
2002年 | 940篇 |
2001年 | 773篇 |
2000年 | 691篇 |
1999年 | 269篇 |
1998年 | 61篇 |
1997年 | 45篇 |
1996年 | 37篇 |
1995年 | 35篇 |
1994年 | 21篇 |
1993年 | 30篇 |
1992年 | 32篇 |
1991年 | 20篇 |
1990年 | 10篇 |
1989年 | 22篇 |
1988年 | 12篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 11篇 |
1983年 | 8篇 |
1982年 | 14篇 |
1981年 | 13篇 |
1980年 | 22篇 |
1979年 | 7篇 |
1978年 | 8篇 |
1977年 | 7篇 |
1969年 | 7篇 |
1921年 | 9篇 |
1919年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Ana Paula H. Yokoyama Silvano Wendel Carolina Bonet-Bub Roberta M. Fachini Ana Paula F. Dametto Fernando Blumm Valeria F. Dutra Gabriela T. P. Candelaria Araci M. Sakashita Rafael Rahal Guaragna Machado Rita Fontão-Wendel Nelson Hamerschlak Ruth Achkar Murillo Santucci Cesar Assunção Patrícia Scuracchio Victor Nudelman Laerte Pastore João R. R. Pinho Mirian Dal Ben Roberto Kalil Filho Alexandre R. Marra Mariane T. Amano Esper G. Kallás Alfredo Salim Helito Carlos Roberto Ribeiro de Carvalho Danielle Bastos Araujo Edison Luiz Durigon Anamaria A. Camargo Luiz V. Rizzo Luiz F. L. Reis Jose M. Kutner 《Transfusion》2021,61(8):2295-2306
992.
Richard M. Burwick Shravya Govindappagari Pedro A. Sanchez‐Lara 《Journal of clinical ultrasound : JCU》2021,49(1):71-73
Situs inversus, a condition in which the major visceral organs are reversed from their normal positions in the body, can be detected by prenatal ultrasonography. Often benign, it may be associated with primary ciliary dyskinesia, an autosomal recessive disorder characterized by chronic respiratory disease. Yet, prenatal diagnosis of primary ciliary dyskinesia has not been reported. We describe a pregnancy in which situs inversus was diagnosed by fetal ultrasound at 20 weeks gestation. Prenatal testing for primary ciliary dyskinesia led to the discovery that both parents were asymptomatic carriers of a pathogenic mutation in the CCDC103 gene, with an affected neonate. 相似文献
993.
Hai‐Qin Liao Ze‐Fang Peng Ming Zhang Yi Tan Min‐Zhi Ouyang Dan Zhou Kui Tang Shi‐Xiong Tang Quan‐Liang Shang 《Journal of clinical ultrasound : JCU》2021,49(1):78-82
Isolated ventricular apical hypoplasia (IVAH) is a rare congenital cardiac anomaly, with clinical manifestations depending on the age of the patient, ranging from no symptoms in children to congestive heart failure or even malignant tachycardia in adults. Herein, we describe the clinical and anatomical findings in four cases with hypoplasia of the right or left ventricular apex, and we discuss the possible mechanisms and differential diagnosis of this malformation. Echocardiography is a rapidly accessible, low cost, noninvasive technique for the detection and evaluation of IVAH. 相似文献
994.
Andrzej Zbek Krzysztof Boczar Ewa Nowosielska‐Zbek Katarzyna Holcman Mateusz Ulman Jacek Lelakowski Barbara Maecka 《Pacing and clinical electrophysiology : PACE》2021,44(1):148-150
The electrocardiogram (ECG) interpretation in patients with implantable cardioverter defibrillator (ICD) is often a puzzling problem. The difficulty of the device function evaluation further increases in the presence of unfamiliar timing cycles and additional functions. We present an interesting ECG with a special function of a Biotronik ICD devices called the thoracic impedance monitoring, and demonstrate its behavior in a patient with atrial fibrillation, pacing beats, ventricular ectopic beats, and couple of ventricular beats. This report shows unexceptional occurrence of tricky ECG finding in patient with Biotronik ICDs. 相似文献
995.
996.
Romina Lomonaco Eddison Godinez Leiva Fernando Bril Sulav Shrestha Lydia Mansour Jeff Budd Jessica Portillo Romero Siegfried Schmidt Ku-Lang Chang George Samraj John Malaty Katherine Huber Pierre Bedossa Srilaxmi Kalavalapalli Jonathan Marte Diana Barb Danielle Poulton Nada Fanous Kenneth Cusi 《Diabetes care》2021,44(2):399
OBJECTIVEAssess the prevalence of nonalcoholic fatty liver disease (NAFLD) and of liver fibrosis associated with nonalcoholic steatohepatitis in unselected patients with type 2 diabetes mellitus (T2DM).RESEARCH DESIGN AND METHODSA total of 561 patients with T2DM (age: 60 ± 11 years; BMI: 33.4 ± 6.2 kg/m2; and HbA1c: 7.5 ± 1.8%) attending primary care or endocrinology outpatient clinics and unaware of having NAFLD were recruited. At the visit, volunteers were invited to be screened by elastography for steatosis and fibrosis by controlled attenuation parameter (≥274 dB/m) and liver stiffness measurement (LSM; ≥7.0 kPa), respectively. Secondary causes of liver disease were ruled out. Diagnostic panels for prediction of advanced fibrosis, such as AST-to-platelet ratio index (APRI) and Fibrosis-4 (FIB-4) index, were also measured. A liver biopsy was performed if results were suggestive of fibrosis.RESULTSThe prevalence of steatosis was 70% and of fibrosis 21% (LSM ≥7.0 kPa). Moderate fibrosis (F2: LSM ≥8.2 kPa) was present in 6% and severe fibrosis or cirrhosis (F3–4: LSM ≥9.7 kPa) in 9%, similar to that estimated by FIB-4 and APRI panels. Noninvasive testing was consistent with liver biopsy results. Elevated AST or ALT ≥40 units/L was present in a minority of patients with steatosis (8% and 13%, respectively) or with liver fibrosis (18% and 28%, respectively). This suggests that AST/ALT alone are insufficient as initial screening. However, performance may be enhanced by imaging (e.g., transient elastography) and plasma diagnostic panels (e.g., FIB-4 and APRI).CONCLUSIONSModerate-to-advanced fibrosis (F2 or higher), an established risk factor for cirrhosis and overall mortality, affects at least one out of six (15%) patients with T2DM. These results support the American Diabetes Association guidelines to screen for clinically significant fibrosis in patients with T2DM with steatosis or elevated ALT. 相似文献
997.
998.
999.
1000.